Sirs: Internal carotid artery dissection (ICAD) is one of the most frequent causes of stroke in young patients [1,2]. Diagnosis may be delayed by misinterpreting local signs of dissection. Typical features of cluster headache (CH) have rarely been reported as presenting symptoms of ICAD [3–7]. Our case shows that subtle clinical features may point to symptomatic forms of CH, and therefore both history taking and clinical examination must be particularly accurate. Three weeks prior to admission, a 38-year-old man had a first attack of severe left-sided retroorbital pain extending into the mouth and ear, fluctuating over three days with pain maximum in the evening. He noted nasal congestion, tearing and hanging of the left eyelid. The pain subsided; however, mild ear pain persisted. An additional pain attack occurred one week later, in the evening, lasting for several hours. The history was negative for headache. A first episode of CH was suspected by his general practitioner. Oral sumatriptan prompted no relief. Thoracic CT was ordered to exclude a mass lesion in the lung apex and ocular pressure was found to be normal. On admission, the main complaint was a new attack of severe left-sided retroorbital and temporal pain. On examination the patient had hyperlacrimation, conjunctival injection and Horner‘s syndrome on the left without any further cranial nerve abnormalities. Oxygen inhalation and local nasal lidocaine were not effective, nasal sumatriptan resulted in partial relief. Neurosonography revealed a resistance flow pattern of the left distal internal carotid artery (ICA) without signs of atherosclerosis. Magnetic resonance imaging (MRI) and angiography (MRA) of the brain and neck demonstrated intramural haematoma and stenosis of the left distal ICA (Fig. 1), but no ischaemic lesions. Based on these findings we diagnosed a left ICAD. Treatment consisted of acetylsalicylic acid (ASA) 100 mg daily for stroke prevention [8] and verapamil 240 mg daily for prophylaxis of pain attacks. The attacks disappeared within two weeks, but a moderate continuous pain persisted in the left lower face. Clinical signs of ICAD are often dissociated with initial pain and local signs followed by retinal or cerebral ischaemic events [1]. In a series of 65 ICAD patients, pain was the presenting symptom in 58.5%, typically unilateral and localized, a painful Horner‘s syndrome was the initial sign in 29%, in two cases, pain mimicked CH [2]. Five similar cases have been reported [3–7]: in all Horner‘s syndrome persisted in pain free intervals, autonomic parasympathetic signs variably included lacrimation, conjunctival injection and nasal congestion, duration and character of pain was less stereotyped than in CH. In ICAD, Horner‘s syndrome is secondary to vessel wall injury affecting the pericarotid sympathetic nerve fibers [1]. The pain of dissection may trigger a physiological trigeminal-autonomic reflex in susceptible patients, resulting in parasympathetic symptoms. Experimentally, this reflex can be activated by painful stimulation of the first trigeminal branch with injection of capsaicin inducing ipsilateral parasympathetic activation as measured by vasodilatation of the ICA [9]. In CH it is hypothesized that increased susceptibility to trigeminal input or increased parasympathetic outflow from the brain stem activate the trigeminalautonomic reflex during an acute attack [10]. In patients with typical pain and autonomic features suggesting CH persistent Horner‘s syndrome, absence of pain free periods, variability in both pain attack duration and pain characteristics, as in our case, should raise suspicion of ICAD. Clinical features alone may not reliably distinguish primary CH from symptomatic forms of CH. Neurosonography as a screening tool [11] and brain MRI with contrast-enhanced MRA for confirmation of the diagnosis are useful in these patients. Treatment recommendations of ICAD are not based on controlled-randomized Dr. M. Hardmeier, MD (&) Prof. C. Gobbi AE Prof. A. Steck Prof. P. Lyrer AE S. Engelter, MD Dept. of Neurology University Hospital Basel Petersgraben 4, 4031 Basel Switzerland Tel.: +41-61/265-4151 Fax: +41-61/265-4100 E-Mail: mhardmeier@uhbs.ch